Serum Extracellular Vesicle-Derived microRNAs as Potential Biomarkers for Pleural Mesothelioma in a European Prospective Study.
biomarkers
early changes
malignant pleural mesothelioma
microRNAs
next generation sequencing
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
25 Dec 2022
25 Dec 2022
Historique:
received:
03
10
2022
revised:
16
12
2022
accepted:
21
12
2022
entrez:
8
1
2023
pubmed:
9
1
2023
medline:
9
1
2023
Statut:
epublish
Résumé
Malignant pleural mesothelioma (MPM) is an aggressive cancer with a dismal prognosis. Early therapeutic interventions could improve patient outcomes. We aimed to identify a pattern of microRNAs (miRNAs) as potential early non-invasive markers of MPM. In a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort, we screened the whole miRNome in serum extracellular vesicles (EVs) of preclinical MPM cases. In a subgroup of 20 preclinical samples collected five years prior MPM diagnosis, we observed an upregulation of miR-11400 (fold change (FC) = 2.6, adjusted
Identifiants
pubmed: 36612122
pii: cancers15010125
doi: 10.3390/cancers15010125
pmc: PMC9817828
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom
Organisme : Italian Association for Cancer Research
ID : 21390
Références
Eur J Cancer. 2010 Sep;46(14):2555-62
pubmed: 20843485
Dis Markers. 2017;2017:9280170
pubmed: 28321148
Biomedicines. 2020 Dec 07;8(12):
pubmed: 33297544
Cells. 2019 Jul 15;8(7):
pubmed: 31311206
Transl Cancer Res. 2021 Apr;10(4):1856-1862
pubmed: 35116507
Front Oncol. 2018 Oct 22;8:446
pubmed: 30406026
Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2524-2540
pubmed: 32699075
J Thorac Oncol. 2016 Dec;11(12):2089-2099
pubmed: 27687963
J Thorac Dis. 2013 Dec;5(6):E254-307
pubmed: 24416529
Precis Cancer Med. 2021 Sep;4:
pubmed: 35098108
Aging (Albany NY). 2022 Jan 30;14(2):728-746
pubmed: 35094981
Sci Rep. 2018 Sep 25;8(1):14321
pubmed: 30254313
Cancers (Basel). 2018 Mar 22;10(4):
pubmed: 29565815
Genes Dev. 2013 Jun 1;27(11):1223-32
pubmed: 23752589
Int J Mol Sci. 2018 Feb 17;19(2):
pubmed: 29462963
Ther Adv Med Oncol. 2020 Nov 12;12:1758835920971421
pubmed: 33240401
Front Genet. 2019 Jul 18;10:626
pubmed: 31379918
Nucleic Acids Res. 2014;42(17):e133
pubmed: 25063298
Nat Rev Clin Oncol. 2018 Oct;15(10):617-638
pubmed: 29795272
Cancers (Basel). 2020 Sep 27;12(10):
pubmed: 32992445
Thorac Surg Clin. 2020 Nov;30(4):367-382
pubmed: 33012427
Sci Rep. 2021 Oct 19;11(1):20645
pubmed: 34667192
JAMA Netw Open. 2021 Aug 2;4(8):e2120360
pubmed: 34379126
Oncotarget. 2017 Dec 14;9(3):3097-3111
pubmed: 29423032
Oncogene. 2015 May 21;34(21):2690-9
pubmed: 25065597
Target Oncol. 2022 Jul;17(4):407-431
pubmed: 35906513
BMC Res Notes. 2019 Feb 11;12(1):77
pubmed: 30744695
Lung Cancer. 2013 Dec;82(3):485-90
pubmed: 24168922
Exp Cell Res. 2015 May 1;333(2):220-227
pubmed: 25728006
PLoS One. 2018 Oct 18;13(10):e0206239
pubmed: 30335862
World J Clin Oncol. 2022 Apr 24;13(4):267-275
pubmed: 35582652
Oncol Lett. 2016 Aug;12(2):871-878
pubmed: 27446362
Bioinformatics. 2020 Apr 15;36(8):2628-2629
pubmed: 31882993
Chest. 2013 Nov;144(5):1632-1643
pubmed: 23828229
Oncotarget. 2018 Apr 03;9(25):17300-17308
pubmed: 29707109
J Pers Med. 2021 Oct 09;11(10):
pubmed: 34683154
Bioengineered. 2021 Dec;12(1):4508-4519
pubmed: 34308752
Int J Mol Sci. 2019 Dec 04;20(24):
pubmed: 31817101
J Thorac Oncol. 2012 Jul;7(7):1184-91
pubmed: 22617246
Int J Mol Sci. 2018 Mar 07;19(3):
pubmed: 29518940
Eur J Cancer. 2022 Mar;163:44-54
pubmed: 35032816
PLoS One. 2017 May 4;12(5):e0176680
pubmed: 28472171
Front Oncol. 2020 Apr 03;10:445
pubmed: 32318342
BMJ Open. 2021 Feb 18;11(2):e039079
pubmed: 33602699
Annu Rev Med. 2018 Jan 29;69:365-377
pubmed: 29029582
Nucleic Acids Res. 2017 Jan 4;45(D1):D812-D818
pubmed: 27899556
Mol Genet Genomic Med. 2020 May;8(5):e1092
pubmed: 32124558
Oncotarget. 2016 Apr 12;7(15):19824-39
pubmed: 26918346
Transl Lung Cancer Res. 2017 Jun;6(3):295-314
pubmed: 28713675
Cells. 2022 Jan 03;11(1):
pubmed: 35011708
Oncology. 2014;86(1):33-43
pubmed: 24401539
Dev Cell. 2019 Aug 5;50(3):264-282
pubmed: 31386861